Press Releases Microbix Biosystems Inc.

Equities

Delayed Toronto S.E. Other stock markets 02:56:40 2024-05-23 pm EDT			5-day change	1st Jan Change
0.325 ^CAD	0.00%		-7.14%	-16.67%

May. 15	Microbix Biosystems Up More Than 10% As Q2 Profit Grows On Higher Revenues; Says Stage Set For Record FY	MT
May. 15	Transcript : Microbix Biosystems Inc., Q2 2024 Earnings Call, May 15, 2024

Microbix Reports Strong Results for Q2 Fiscal 2024	May. 15	GL
Microbix Schedules Release of Results for Q2 Fiscal 2024	May. 08	GL
Microbix Collaborator Introduces New Lab Accreditation Program	Apr. 25	GL
Microbix Presenting at the 2024 Bloom Burton Conference	Apr. 11	GL
Microbix Announces Annual and Special Meeting Voting Results	Apr. 01	GL
Microbix’s Clot-Buster Drug Project Advances	Mar. 14	GL
Microbix Unveils Test Controls for Head and Neck Cancer	Mar. 11	GL
Microbix Unveils Test Controls for Head and Neck Cancer	Mar. 11	AQ
Microbix Announces Issuance of Stock Options	Feb. 26	GL
Microbix Reports Record Results for Q1 Fiscal 2024	Feb. 14	GL
Microbix Schedules Release of Results for Q1 Fiscal 2024	Feb. 07	GL
Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen	Feb. 06	AQ
Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen	Feb. 06	GL
Microbix Achieves Further QAPs Sales Record	Jan. 03	GL
Microbix Achieves Further QAPs Sales Record	Jan. 03	AQ
Microbix Reports Results for Q4 & Full-Year Fiscal 2023	Dec. 21	GL
Microbix Biosystems : Reports Results for Q4 & Full-Year Fiscal 2023	Dec. 21	PU
Microbix Biosystems : Earnings Document	Dec. 20	PU
Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy	Dec. 14	GL
Microbix Biosystems : & Seegene USA Jointly Enhancing Lab Test Accuracy	Dec. 14	PU

No results for this search